Credit: Getty Images In the second part of a 2-part series with Cardiology Advisor, Endocrinology Advisor interviewed a patient who shared her experiences with fatphobia in the clinical setting. In ...

Among patients who underwent laparotomy, the risk for surgical site infection and wound dehiscence was significantly reduced with staples plus incisional negative pressure wound therapy vs staples ...

Higher BMI statuses were associated with improved survival among patients with prostate cancer, especially those with metastatic disease. Overweight and obesity are associated with improved overall ...

Private equity hospitals reduced ED and ICU salary expenditures after acquisition relative to control hospitals. HealthDay News — U.S. hospitals that undergo private equity acquisition may reduce ...

Progress in cancer research, including approval of 20 new anticancer therapeutics in the past year, is described in the 15th edition of the AACR Cancer Progress Report.

Pregnant people should stay away from cannabis, and doctors should ask all patients about its use before, during and after pregnancy.

The pooled prevalence of stroke/TIA among patients with TA was 10.7% in the literature, with higher rates found among men and European populations.

The association between triglyceride-glucose index and reduced lung function was stronger in male vs female individuals. Increased triglyceride-glucose index (TyG) values are strongly associated with ...

Compared with other measures of hypertension, the American Heart Association’s stage II hypertension category had the strongest association with disability worsening in patients with multiple ...

Guidelines regarding the management of patients with valvular heart disease have been published by the European Society of Cardiology and EACTS.

In adults with obesity and those with type 2 diabetes and obesity, once-weekly semaglutide 7.2 mg is superior to placebo for body weight reduction.

The FDA has expanded the approval of Evkeeza® (evinacumab-dgnb) to include children aged 1 year and older with homozygous familial hypercholesterolemia.